Our cumulative results provide proof of concept for AAV-mediated SGPL1 gene transfer as a potentially curative therapy for SPLIS and provide insight into the possible pathomechanism of SPLIS nephrosis. The gene discussed is SGPL1; the disease is nephrosis.